COGT Cogent Biosciences, Inc.

Formerly Unum Therapeutics Inc., the company is a biotechnology company focused on developing precision therapies for genetically defined diseases.

$8.55  -0.75 (-8.07%)
As of 06/22/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  03/29/2018
Outstanding shares:  38,410,267
Average volume:  289,345
Market cap:   $356,063,175
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -6.23
PB ratio:   1.58
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy